Literature DB >> 14744157

DNA enzyme generated by a novel single-stranded DNA expression vector inhibits expression of the essential bacterial cell division gene ftsZ.

Xin-Xing Tan1, Knesha Rose, William Margolin, Yin Chen.   

Abstract

Rapid emergence of antibiotic-resistant bacterial pathogens has created urgent demand for the discovery and development of new antibacterial agents directed toward novel targets. Antisense oligodeoxynucleotides (AS-ODN) and their modified forms have been utilized to block gene expression in bacterial cells, showing potential for developing highly specific and efficacious antibacterial agents. In this study, a tetracycline-regulated expression vector was developed for generating single-stranded DNA (ssDNA) of a desired target sequence in bacterial cells. This inducible ssDNA expression vector was tested for producing a DNA enzyme designed to specifically cleave ftsZ mRNA. Our results indicate that the expressed DNA enzyme molecules not only repress ftsZ gene expression and but also inhibit bacterial cell proliferation. Although we believe that the cleavage of ftsZ mRNA by the expressed DNA enzyme molecules is responsible for the inhibitory effects on ftsZ gene expression and bacterial cell proliferation, the antisense mechanism could also be responsible for the biological effects. The ability of this ssDNA expression system to selectively modulate gene expression may provide a powerful strategy in determining the contribution of a given gene product to bacterial growth or pathogenesis and opens a new venue for developing antibacterial agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744157     DOI: 10.1021/bi035164h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  DNA targeting of rhinal cortex D2 receptor protein reversibly blocks learning of cues that predict reward.

Authors:  Zheng Liu; Barry J Richmond; Elisabeth A Murray; Richard C Saunders; Sara Steenrod; Barbara K Stubblefield; Deidra M Montague; Edward I Ginns
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

Review 2.  Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Authors:  Ravinay Bhindi; Roger G Fahmy; Harry C Lowe; Colin N Chesterman; Crispin R Dass; Murray J Cairns; Edward G Saravolac; Lun-Quan Sun; Levon M Khachigian
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

3.  Silencing of Essential Genes within a Highly Coordinated Operon in Escherichia coli.

Authors:  Shan Goh; Angela Hohmeier; Timothy C Stone; Victoria Offord; Francisco Sarabia; Cristina Garcia-Ruiz; Liam Good
Journal:  Appl Environ Microbiol       Date:  2015-06-12       Impact factor: 4.792

4.  Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.

Authors:  Xin-Xing Tan; Jeffrey K Actor; Yin Chen
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Deoxyribozymes: new therapeutics to treat central nervous system disorders.

Authors:  Barbara Grimpe
Journal:  Front Mol Neurosci       Date:  2011-09-23       Impact factor: 5.639

Review 6.  RNA-cleaving DNAzymes as a diagnostic and therapeutic agent against antimicrobial resistant bacteria.

Authors:  Bao Chi Wong; Juwaini Abu Bakar; Amreeta Dhanoa; Hock Siew Tan
Journal:  Curr Genet       Date:  2021-09-09       Impact factor: 3.886

Review 7.  In vitro selection, characterization, and application of deoxyribozymes that cleave RNA.

Authors:  Scott K Silverman
Journal:  Nucleic Acids Res       Date:  2005-11-11       Impact factor: 16.971

Review 8.  The application of Tet repressor in prokaryotic gene regulation and expression.

Authors:  Ralph Bertram; Wolfgang Hillen
Journal:  Microb Biotechnol       Date:  2008-01       Impact factor: 5.813

9.  Hitting bacteria at the heart of the central dogma: sequence-specific inhibition.

Authors:  Louise Carøe Vohlander Rasmussen; Hans Uffe Sperling-Petersen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2007-08-10       Impact factor: 5.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.